Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 2.4 % BTX opened at $1.80 on Friday. The company has a market cap of $105.59 million, a price-to-earnings ratio of -0.79 and […]
More Stories
Ameritas Advisory Services LLC Purchases 459 Shares of CSX Corporation (NASDAQ:CSX)
Ameritas Advisory Services LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 4.1% in the...
KBC Group NV Trims Stock Position in Tyson Foods, Inc. (NYSE:TSN)
KBC Group NV lessened its holdings in shares of Tyson Foods, Inc. (NYSE:TSN – Free Report) by 12.2% in the...
Amalgamated Bank Sells 1,496 Shares of Ingredion Incorporated (NYSE:INGR)
Amalgamated Bank cut its holdings in Ingredion Incorporated (NYSE:INGR – Free Report) by 4.7% in the 1st quarter, according to...
Meta Platforms, Inc. (NASDAQ:META) Shares Acquired by Waterfront Wealth Inc.
Waterfront Wealth Inc. lifted its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 6.9% during the...
Buttonwood Financial Advisors Inc. Decreases Holdings in Meta Platforms, Inc. (NASDAQ:META)
Buttonwood Financial Advisors Inc. cut its position in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 3.9% during...
Monument Capital Management Raises Stock Position in Meta Platforms, Inc. (NASDAQ:META)
Monument Capital Management raised its stake in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 248.4% in the first quarter,...